← Back to Patent Explorer
US4374765A Expired / Lapsed US ⏱️ 0.0 years remaining

Mammalian collagenase inhibitors

Assignee: Wyeth LLC
•
Filing: 1981-10-07
•
Granted: 1983-02-22
•
Expires: 2001-10-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The polypeptides R-Gly-L-Cys-Gly-L-Glu-L-Glu-NH 2 or a pharmaceutically acceptable salt thereof act as collagenase inhibitors useful in the treatment of disease involving excessive tissue destruction by collagenase.

Inventors

  • 👤 William H. McGregor

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 19:08
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/06; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 39 words
A compound of the formula: R-Gly-L-Cys-Gly-L-Glu-L-Glu-NH.sub.2 in which R is hydrogen, alkanoyl of 2 to 6 carbon atoms, cycloalkylcarbonyl of 6 to 8 carbon atoms or alkoxycarbonyl of 2 to 6 carbon atoms; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 39 words
A compound of the formula: R-Gly-L-Cys-Gly-L-Glu-L-Glu-NH.sub.2 in which R is hydrogen, alkanoyl of 2 to 6 carbon atoms, cycloalkylcarbonyl of 6 to 8 carbon atoms or alkoxycarbonyl of 2 to 6 carbon atoms; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 17 words
The compound of claim 1 which is CH 3 CO-Gly-L-Cys-Gly-L-Glu-L-Glu-NH 2 or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US4276284A Cited
JPS5328165A Cited
US4235885A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-02-21 1986-08-23 1987-02-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-02-21 1990-08-23 1991-02-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-02-21 1994-08-23 1995-02-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag